Literature DB >> 29687029

De Novo KCNQ2 Mutation in One Case of Epilepsy of Infancy With Migrating Focal Seizures That Evolved to Infantile Spasms.

Haolin Duan1, Jing Peng1, Miriam Kessi1, Fei Yin1.   

Abstract

Epilepsy of infancy with migrating focal seizures (EIMFS) is a rare type of early-onset epileptic encephalopathy that is characterized by refractory migratory multifocal seizures that migrate between hemispheres. Its etiology is not well known although it is postulated to occur due to channelopathy. The authors report the first case of EIMFS due to a de novo heterozygous mutation in exon 4(c.881C>T missense mutation, p.Ala294Val, NM_172107.2) in KCNQ2 gene which later evolved into infantile spasms. However, it is the second case of EIMFS with KCNQ2 mutation. He presented with multifocal migratory partial seizures which started at the age of 8 days. Electroencephalogram examination revealed multifocal interictal spikes that migrated from one hemisphere to the other within a seizure. It was intractable with antiepileptic drugs and adrenocorticotropic hormone. He later developed spasms from the age of 8 months. Consequently, our case supports the new association between EIMFS and KCNQ2 mutations. Moreover, it enriches the disease phenotype because of transformation.

Entities:  

Keywords:  KCNQ2 gene mutation; epilepsy of infancy with migrating focal seizures; infantile spasms.

Year:  2018        PMID: 29687029      PMCID: PMC5900813          DOI: 10.1177/2329048X18767738

Source DB:  PubMed          Journal:  Child Neurol Open        ISSN: 2329-048X


KCNQ2 gene (OMIM 602235) encodes for subunits of potassium channels. It associates with both benign neonatal familial seizures (BNFSs) and early-onset epileptic encephalopathy (EOEE)[1] Spagnoli et al reported the first case of epilepsy of infancy with migrating focal seizures (EIMFS-like) which had KCNQ2 mutation.[2] Therefore, ours is the second case. Here, the authors report a patient with a de novo KCNQ2 mutation who presented with EIMFS in early infancy, but later he had a presentation consistent with infantile spasms (ISs). This supports the relationship between KCNQ2 mutations and EIMFS.

Case Report

The patient was a twin baby boy who was born at term through a cesarean section at gestation age of 37 weeks and weighed 2.74 kg. His family history of epilepsy or hereditary diseases is unremarkable. He has a twin sister who is fine. He had uncontrollable seizures that began at the age of 8 days, but he was seen in our hospital at the age of 32 days. Seizures were tonic in nature, migrated from one side of the body to another side involving both the upper limbs and lower limbs. Additionally, seizures were accompanied by on and off apneic attacks, rolling of the eyes and head to one side. Multiple attacks were encountered per day, and each episode took about 20 seconds to 1 minute. Physical examination revealed him to have a weight of 2.82 kg (< 3rd percentile), and head circumference was 36 cm (50-85th percentile). Neurological evaluation revealed him to have developmental delay and poor eye focus. First video electroencephalogram (EEG) which was done at the age of 32 days (Supplemental Figure S2A, S2B and S2C) showed burst-suppression pattern during sleep, hypsarrythmia, and it captured 2 myoclonic seizures. The second video EEG which was done at the age of 40 days (Figure 1) showed multifocal interictal spikes and partial seizures arising from the right and left parietal lobes independently, at times with migration from one hemisphere to the other within a seizure.
Figure 1.

Electroencephalogram which was done at the age of 40 days showing seizures originating from the left parietal region (left arrow in Figure 1). After 30 seconds, ictal discharges shift to the right rear-temporal region, and then after 60 seconds, the seizures terminated (right arrow in Figure 1). It signifies migratory epileptic activity which is typical for epilepsy of infancy with migrating focal seizures (EIMFS).

Electroencephalogram which was done at the age of 40 days showing seizures originating from the left parietal region (left arrow in Figure 1). After 30 seconds, ictal discharges shift to the right rear-temporal region, and then after 60 seconds, the seizures terminated (right arrow in Figure 1). It signifies migratory epileptic activity which is typical for epilepsy of infancy with migrating focal seizures (EIMFS). Magnetic resonance imaging of the brain was normal. Laboratory investigations for inborn errors of metabolism were performed which yielded no significant results. Treatment was attempted with multiple antiepileptic drugs without any significant improvement. Administered drugs included midazolam, phenobarbital, levetiracetam, sodium valproate, topiramate, and adrenocorticotropic hormone. Comprehensive epilepsy DNA sequencing panel was performed which identified a de novo heterozygous mutation in exon 4 (c.881C>T missense mutation, p.Ala294Val, NM_172107.2) in KCNQ2 gene. The mutation which was confirmed by direct Sanger sequencing was not found in either parent (Supplemental Figure S4). He developed clusters of flexion spasms involving the trunk and the extremities from the age of 8 months. They were noticed more prior sleeping and waking up. The last evaluation was done at the age of 15 months, and he was found to have uncontrollable seizures and severe developmental delay, as he could hardly control his head and he had no speech. He had microcephaly head circumference below the third percentile (44.5 cm) and normal body weight. EEG revealed a series of seizures and multifocal epileptiform activities (Supplemental Figure S3A and S3B).

Discussion

Epilepsy of infancy with migrating focal seizures is a rare type of EOEE that occurs in infants aged below 6 months. Its etiology is poorly understood but postulated to occur due to genetic causes. Recently, de novo KCNT1 gene mutations were described as pathogenic variation in about 50% of all cases with EIMFS.[1] Moreover, few gene mutations have been reported to associate with this condition including TBC1D24 mutation[3] and SCN1A missense mutation.[1] The fact that some patients with EIMFS failed to reveal genetic abnormalities in those genes point out the probability of having other undiscovered pathogenic genes. The clinical presentation of our patient together with EEG findings met the criteria for the diagnosis of EIMFS according to Coppola et al.[4] Our patient presented with early-onset seizures at the age of 8 days which was recurrent migrating multifocal seizures involving eyes and limbs, and it was associated with psychomotor developmental delay and poor response to multiple drugs that concurs with other reported cases. Ictal phase in EEG was characterized by migratory sharp and spike waves that were shifting from left hemisphere to the right hemisphere, which concurs with diagnostic criteria for EIMFS. One case of KCNQ2 mutation with EEG findings similar to EIMFS was reported by Spagnoli et al.[2] At the age of 1 month, EEG was characterized by hypsarrythmia and burst suppression pattern without spasms. He developed spasms later from the age of 8 months, and diagnosis of infantile spasms (ISs) was made. Lee et al[5] described 1 case of EIMFS which evolved to IS similar to our case, and he considered that EIMFS can be a continuum of infantile epileptic encephalopathy. The patient was found to have a de novo heterozygous mutation (c.881C>T, p.Ala294 Val) in KCNQ2 gene by next-generation sequencing epilepsy panels. KCNQ2 gene is responsible for encoding a voltage-gated potassium channel. And the KCNQ2-related epilepsy spectrum range from KCNQ2-related benign neonatal familial seizures (KCNQ2-BFNS) with mild outcome to KCNQ2-related EOEE (KCNQ2-EOEE) with severe outcome.[6] KCNQ2 gene mutation is acknowledged to cause different kinds of seizures including BNFS which occurs commonly due to p.Ala294Gly mutation and EOEE which occurs commonly due to p.Ala294Val mutation.[7] The authors found 10 cases of EOEE who were reported to carry the same mutation c.881C>T (p.Ala294Val) as shown in Table 1.[6-9] Interestingly, our patient’s initial epileptic features were similar to KCNQ2-EOEE patients. He shared some common features with this syndrome, such as onset in infancy (below 1 month), tonic seizures, severe developmental delay, and burst suppression pattern in EEG. Nevertheless, he developed features of IS later. However, it is not the first case that had transition due to KCNQ2 gene mutation. Samanta et al[10] reported a case of myoclonic epilepsy that evolved into IS, and Milh et al[6] and Kato et al[8] reported cases of OS which evolved to IS.
Table 1.

Main Clinical Features of the Patients with KCNQ2-Related Encephalopathy Due to c.881C>T p.A294 V KCNQ2 Gene Mutation.a

Patient noCharacter of the SeizureInheritanceEEG AppearanceDiagnosisSeizure ProgressOutcomeReference
1TDe novoMultifocal discharges, discontinuous, asynchronousKCNQ2- EncephalopathySeizure free at 5 monthsDD8
2CDe novoSuppression burstOSSeizures free at 3 monthsDD5
3TDe novoSuppression burstOS2-9 years: seizure-free. > 9 years: monthly GTC seizures.DD5
4MDe novoSuppression-burstOSSeizure free at 3 monthsDD5
5TDe novoSuppression burst, hypsarrhythmia at 3 monthsOSSeizure free at 6 monthsDD7
6TDe novoSuppression-burstOSIntractable seizureDD7
7TInheritedSuppression-burstOSSeizure free at 2 monthsDD6
8TDe novoSuppression-burstOSUnknown, death at 6 weeksDD6
9TInheritedSlow background activity, and bilateral dischargesEOEESeizure free at 3 monthsDD6
10TDe novoSuppression-burstOSSeizure free at 3 monthsDD6
11T (F or G)De novoSuppression-burst, hypsarrythmia and migrationEIMFSIntractable seizureDDThis case

Abbreviations: C, clonic; DD, developmental delay; EOEE, early-onset epileptic encephalopathy; EIMFS, epilepsy of infancy with migrating focal seizures; F, focal seizure; G, generalized seizure; GTC, generalized tonic clonic; M, myoclonic; OS, ohtahara syndrome.

aTable summarizing the main clinical features of the previous patients reported to have KCNQ2-related encephalopathy due to c.881C>T p.A294 V KCNQ2 gene mutation in comparison with our patient.

Main Clinical Features of the Patients with KCNQ2-Related Encephalopathy Due to c.881C>T p.A294 V KCNQ2 Gene Mutation.a Abbreviations: C, clonic; DD, developmental delay; EOEE, early-onset epileptic encephalopathy; EIMFS, epilepsy of infancy with migrating focal seizures; F, focal seizure; G, generalized seizure; GTC, generalized tonic clonic; M, myoclonic; OS, ohtahara syndrome. aTable summarizing the main clinical features of the previous patients reported to have KCNQ2-related encephalopathy due to c.881C>T p.A294 V KCNQ2 gene mutation in comparison with our patient. In conclusion, our case report supports the relationship between KCNQ2 mutation and EIMFS. Moreover, it enriches the disease phenotype because of transformation. Click here for additional data file. Supplementary_materials for De Novo KCNQ2 Mutation in One Case of Epilepsy of Infancy With Migrating Focal Seizures That Evolved to Infantile Spasms by Haolin Duan, Jing Peng, Miriam Kessi, and Fei Yin in Child Neurology Open
  10 in total

1.  A recurrent KCNQ2 pore mutation causing early onset epileptic encephalopathy has a moderate effect on M current but alters subcellular localization of Kv7 channels.

Authors:  Affef Abidi; Jérôme J Devaux; Florence Molinari; Gisèle Alcaraz; François-Xavier Michon; Julie Sutera-Sardo; Hélène Becq; Caroline Lacoste; Cécilia Altuzarra; Alexandra Afenjar; Cyril Mignot; Diane Doummar; Bertrand Isidor; Sylvie N Guyen; Estelle Colin; Sabine De La Vaissière; Damien Haye; Adeline Trauffler; Catherine Badens; Fabienne Prieur; Gaetan Lesca; Laurent Villard; Mathieu Milh; Laurent Aniksztejn
Journal:  Neurobiol Dis       Date:  2015-05-22       Impact factor: 5.996

2.  Myoclonic epilepsy evolved into West syndrome: a patient with a novel de novo KCNQ2 mutation.

Authors:  Debopam Samanta; Raghu Ramakrishnaiah; Erin Willis; Richard E Frye
Journal:  Acta Neurol Belg       Date:  2014-08-05       Impact factor: 2.396

3.  Characterization of two de novoKCNT1 mutations in children with malignant migrating partial seizures in infancy.

Authors:  Francesca Rizzo; Paolo Ambrosino; Anna Guacci; Massimiliano Chetta; Giovanna Marchese; Teresa Rocco; Maria Virginia Soldovieri; Laura Manocchio; Ilaria Mosca; Gianluca Casara; Marilena Vecchi; Maurizio Taglialatela; Giangennaro Coppola; Alessandro Weisz
Journal:  Mol Cell Neurosci       Date:  2016-01-16       Impact factor: 4.314

Review 4.  Malignant migrating partial seizures in infancy.

Authors:  Giangennaro Coppola
Journal:  Handb Clin Neurol       Date:  2013

5.  Clinical spectrum of early onset epileptic encephalopathies caused by KCNQ2 mutation.

Authors:  Mitsuhiro Kato; Takanori Yamagata; Masaya Kubota; Hiroshi Arai; Sumimasa Yamashita; Taku Nakagawa; Takanari Fujii; Kenji Sugai; Kaoru Imai; Tami Uster; David Chitayat; Shelly Weiss; Hirofumi Kashii; Ryosuke Kusano; Ayumi Matsumoto; Kazuyuki Nakamura; Yoshinobu Oyazato; Mari Maeno; Kiyomi Nishiyama; Hirofumi Kodera; Mitsuko Nakashima; Yoshinori Tsurusaki; Noriko Miyake; Kayoko Saito; Kiyoshi Hayasaka; Naomichi Matsumoto; Hirotomo Saitsu
Journal:  Epilepsia       Date:  2013-04-26       Impact factor: 5.864

6.  A case of malignant migrating partial seizures in infancy as a continuum of infantile epileptic encephalopathy.

Authors:  Eun Hye Lee; Mi-Sun Yum; Min-Hee Jeong; Kyung Yeon Lee; Tae-Sung Ko
Journal:  Brain Dev       Date:  2011-12-24       Impact factor: 1.961

7.  KCNQ2 encephalopathy: A case due to a de novo deletion.

Authors:  Carlotta Spagnoli; Grazia Gabriella Salerno; Alessandro Iodice; Daniele Frattini; Francesco Pisani; Carlo Fusco
Journal:  Brain Dev       Date:  2017-07-17       Impact factor: 1.961

8.  Novel compound heterozygous mutations in TBC1D24 cause familial malignant migrating partial seizures of infancy.

Authors:  Mathieu Milh; Antonio Falace; Nathalie Villeneuve; Nicola Vanni; Pierre Cacciagli; Stefania Assereto; Rima Nabbout; Fabio Benfenati; Federico Zara; Brigitte Chabrol; Laurent Villard; Anna Fassio
Journal:  Hum Mutat       Date:  2013-04-12       Impact factor: 4.878

9.  The variable phenotypes of KCNQ-related epilepsy.

Authors:  Nicholas M Allen; Maria Mannion; Judith Conroy; Sally A Lynch; Amre Shahwan; Bryan Lynch; Mary D King
Journal:  Epilepsia       Date:  2014-07-22       Impact factor: 5.864

10.  Similar early characteristics but variable neurological outcome of patients with a de novo mutation of KCNQ2.

Authors:  Mathieu Milh; Nadia Boutry-Kryza; Julie Sutera-Sardo; Cyril Mignot; Stéphane Auvin; Caroline Lacoste; Nathalie Villeneuve; Agathe Roubertie; Bénédicte Heron; Maryline Carneiro; Anna Kaminska; Cécilia Altuzarra; Gaëlle Blanchard; Dorothée Ville; Marie Anne Barthez; Delphine Heron; Domitille Gras; Alexandra Afenjar; Nathalie Dorison; Dianne Doummar; Thierry Billette de Villemeur; Isabelle An; Aurélia Jacquette; Perrine Charles; Julie Perrier; Bertrand Isidor; Laurent Vercueil; Brigitte Chabrol; Catherine Badens; Gaétan Lesca; Laurent Villard
Journal:  Orphanet J Rare Dis       Date:  2013-05-22       Impact factor: 4.123

  10 in total
  2 in total

1.  Bi-allelic ADARB1 Variants Associated with Microcephaly, Intellectual Disability, and Seizures.

Authors:  Tiong Yang Tan; Jiří Sedmík; Mark P Fitzgerald; Rivka Sukenik Halevy; Liam P Keegan; Ingo Helbig; Lina Basel-Salmon; Lior Cohen; Rachel Straussberg; Wendy K Chung; Mayada Helal; Reza Maroofian; Henry Houlden; Jane Juusola; Simon Sadedin; Lynn Pais; Katherine B Howell; Susan M White; John Christodoulou; Mary A O'Connell
Journal:  Am J Hum Genet       Date:  2020-03-26       Impact factor: 11.025

Review 2.  Capturing seizures in clinical trials of antiseizure medications for KCNQ2-DEE.

Authors:  John J Millichap; Cynthia L Harden; Dennis J Dlugos; Jacqueline A French; Noam N Butterfield; Celene Grayson; Ernesto Aycardi; Simon N Pimstone
Journal:  Epilepsia Open       Date:  2021-01-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.